Corporate Updates

Klas Teleradiology Solutions sets up a new Clinical trial imaging core lab

Teleradiology Solutions, the Klas rated Number one national teleradiology provider, has entered the Clinical Trials Imaging Market with the creation of its niche unit- Image Core Lab (ICL). The new entity has been formed recognizing that medical imaging now plays an increasing role in the development of new therapeutics, either as a surrogate endpoint or an endpoint in its own right. Image Core Lab (ICL) is leveraging the combined 10-year experience of its creators – Teleradiology Solutions ( in services and TeleradTechs RadSpa ( in technology and workflow development to offer a range of services in the Management and Review of Imaging in Clinical Trials. ICL is positioned to assist sponsors and CROs in the clinical trial arena where medical images are involved.


As its opening event, Image Core Lab in collaboration with the Drug Information Association (DIA) and Teleradiology Solutions is conducting an intensive one-day workshop on imaging in clinical trials on July 27th in Bangalore. In this program, distinguished international faculty speakers will review the current practice of imaging biomarkers in clinical trials. Additionally, participants will be oriented on newer imaging modalities and the latest imaging criteria with a specific focus on quantitative imaging. The course content will focus on the need for consistency, accuracy and reproducibility of imaging data in clinical trials and how to achieve this.

Ankita Puri, Head of New Business Development for ICL says The regulatory issues to standardize the data and to remove bias from site uation have also led to the strong need for centralized labs such as ICL. We are confident that ICL will provide a high-value service to the Pharma, Biotech and CRO industries and give them significant impetus in the imaging component of their drug development activities. The forthcoming workshop will serve to increase awareness of the role Imaging plays today in Clinical trials




Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top